Leadership & Pay ·
Aspira Women's Health Inc. entered into a separation agreement with former CEO Michael Buhle, who ceased serving as…
AWHLAspira Women's Health Inc.
Aspira Women's Health Inc. entered into a separation agreement with former CEO Michael Buhle, who ceased serving as CEO effective June 17, 2026. The agreement, expected to be effective on or about July 6, 2026, includes a $200,000 cash severance package, six months of COBRA health insurance premiums, and accelerated vesting of 64,583 stock options at a $0.07 exercise price. Shares acquired through exercise of these options will be subject to lock-up and volume/price floor restrictions. Aspira Women's Health Inc. provides women's health diagnostic services.